Fresenius Medical Care AG (FMS) has a MoatMap StockRank of 96/100 based on Quality (52/100), Value (80/100), and Momentum (54/100) factor scores. The current signal is STRONG BUY. Fresenius Medical Care is a dialysis provider facing structural headwinds, high debt, and low return on capital (Q: 52). It does not possess the pricing power or reinvestment runway required for a high-conviction compounder.
Fresenius Medical Care AG is the world's leading provider of products and services for individuals with renal diseases, operating a vast global network of dialysis clinics. The company is vertically integrated, manufacturing its own dialysis machines and consumables while simultaneously providing patient care. Its competitive moat is sustained by its unmatched global scale, high regulatory barriers to entry, and long-term patient relationships.
| Price | $21.93 |
| Market Cap | $11.6B |
| P/E (TTM) | 11.35 |
| P/E (Forward) | 5.48 |
| Price/Book | 0.77 |
| Return on Equity | 7.9% |
| Return on Invested Capital | 7.7% |
| Debt/Equity | 77.75 |
| Gross Margin | 26.0% |
| Operating Margin | 8.1% |
| Revenue Growth | -5.5% |
| Dividend Yield | 4.0% |
| Free Cash Flow | $1.7B |
Fresenius Medical Care AG operates in the Medical Care Facilities industry, part of the Healthcare sector (Germany).